Development of Large-Scale Downstream Processing for Lentiviral Vectors
نویسندگان
چکیده
منابع مشابه
MANUFACTURING Downstream Technology Landscape for Large - Scale Therapeutic Cell Processing
T he cell therapy industry (CTI) is poised to grow rapidly over the next decade, treating millions of patients and generating annual revenues into the tens of billions of US dollars (1, 2). To meet that high-growth demand, large CTI system manufacturers (e.g., Corning, Nunc/Nalgene, and GE Healthcare) and leading contract manufacturing organizations (CMOs, such as Lonza) are developing and inte...
متن کاملBeta thalassemia gene therapy using lentiviral vectors
Recent years, allogeneic bone marrow transplantation (BMT) has proved to be the successful cure for patients with thalassemia major, however this is restricted due to limited matched-related donor. Its complications include chronic graft-versus-host disease in 5-8% of patients. So, a molecular approach, such as gene therapy for direct normal beta globin gene transmission, seems quite promising ...
متن کاملEfficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo.
The aim of this study was to develop an efficient method for packaging and concentrating lentiviral vectors that consistently yields high-titer virus on a scale suitable for in vivo applications. Transient cotransfection of 293T packaging cells with DNA plasmids encoding lentiviral vector components was optimized using SuperFect, an activated dendrimer-based transfection reagent. The use of Sup...
متن کاملDevelopment of lentiviral vectors for gene therapy for human diseases.
Retroviral vectors derived from murine retroviruses are being used in several clinical gene therapy trials. Recently, progress has been made in the development of vectors based on the lentivirus genus of retroviruses, which ironically includes a major human pathogen, human immunodeficiency virus (HIV). As these vector systems for clinical gene transfer are developed, it is important to understa...
متن کاملRe-design of Downstream Processing Techniques for Nanoparticulate Bioproducts
There has been much interest generated in the recovery of nanoparticulate (nanoparticle) bioproducts(Second generation of biotechnological products) such as plasmid DNA and viruses as putative gene therapyvectors, macromolecular assemblies as drug delivery vehicles and virus-like particles as vaccine components.Such product must be manufactured in advanced stages of purity, ma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Therapy - Methods & Clinical Development
سال: 2020
ISSN: 2329-0501
DOI: 10.1016/j.omtm.2020.03.025